Loqus23 Therapeutics Limited is an active company incorporated on 29 March 2019 with the registered office located in Cambridge, Cambridgeshire. Loqus23 Therapeutics Limited was registered 6 years ago.
Accounts for a small company made up to 31 March 2025
Submitted on 23 Jul 2025
Confirmation statement made on 28 March 2025 with updates
Submitted on 2 Apr 2025
Appointment of Dr Cyrus Mozayeni as a director on 30 January 2025
Submitted on 24 Feb 2025
Registered office address changed from Building 522, Ivan De Burgh Room Babraham Research Campus Cambridge CB22 3AT United Kingdom to Suite 7 Mcclintock Building Granta Park Great Abington Cambridgeshire CB21 6GP on 7 February 2025
Submitted on 7 Feb 2025
Change of details for Dementia Discovery Gp Lp. as a person with significant control on 6 September 2024
Submitted on 21 Jan 2025
Cessation of Novartis Ag as a person with significant control on 6 September 2024
Submitted on 20 Jan 2025
Change of details for Ddf Parallel Llp as a person with significant control on 6 September 2024
Submitted on 20 Jan 2025
Notification of Novartis Ag as a person with significant control on 9 November 2021
Submitted on 20 Jan 2025
Change of details for Dementia Discovery Gp Lp. as a person with significant control on 9 November 2021
Submitted on 15 Jan 2025
Change of details for Ddf Parallel Llp as a person with significant control on 9 November 2021